About Kite Pharma and Gilead Sciences

In the Nordic countries, Kite Pharma operates as part of the local Gilead Sciences affiliate in each Nordic country. Read more below on Kite Pharma and Gilead Sciences.

About Kite

Our mission: Transformational cancer treatment

At Kite, our singular focus is cell therapy to treat and potentially cure cancer. Our goal is to bring the promise of cell therapy to as many eligible patients as possible who may benefit.

We believe cell therapy has the ability to change the way cancer is treated. Our industry-leading cell therapy technology uses the power of a patient’s own immune system (their white blood cells) to target and attack their cancer cells.

Our story

Kite was founded in 2009 as a pioneer in cell therapy research. Since our acquisition by biopharma leader Gilead Sciences in October 2017, our combined strength has accelerated the advancement of our pipeline, including the launch of YESCARTA® (axicabtagene ciloleucel) and TECARTUS® (brexucabtagene autoleucel), and has expanded the impact of our strategic partnerships.

As an independent operating company since 2019, we prioritize innovative R&D with the full resources, capabilities, and trust of Gilead. As a vital part of Gilead, we are devoted to advancing the understanding of cell therapy as a transformational treatment option for cancer. The combined strength of Kite and Gilead allows us to remain innovative, agile, and ambitious in our mission to keep improving the lives of people with all types of cancer.

Kite has locations around the globe, including our corporate headquarters in Santa Monica, California, our cell therapy manufacturing facilities in El Segundo, California and Frederick, Maryland, and our European cell therapy manufacturing facility in Amsterdam.

Our industry-leading manufacturing facilities deliver cell therapies rapidly and reliably to people across the globe. As we continue to grow and expand, we are investing in manufacturing and technical advances that will help us meet the needs of the future.

About Gilead Sciences

Our mission

At Gilead, we’re committed to creating a healthier world for everyone – no matter the challenges ahead of us. For more than 30 years, we’ve pursued the impossible, chased it down, tackled it for answers and surrounded it for a way in. We have worked tirelessly to bring forward medicines for life-threatening diseases.

Through bold and transformative science, we’re driving innovation that has the potential to become the next generation of life-changing medicines. Our ambition is evident in our mission. Because the impossible is not impossible. It’s what’s next.

Our Story

Gilead is committed to advancing care for people around the world, by bringing forward medicines in areas of unmet medical need. We do this through internal research and development, as well as through collaborations with academic and industry partners.

Since 1987, Gilead has delivered more than 25 innovative medicines, helping to improve treatment for people living with diseases such as HIV, viral hepatitis, cancer and other conditions.

Foster City, California, is home to the company’s worldwide corporate headquarters.

SE-TEC-0042 | 09/2024